A Randomized Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs. Cyclophosphamide Alone in the Treatment of Lupus Nephritis - The Start Up Phase of Clinical Trial ITN #INT034AI

Grant

Date/time Interval

  • January 1, 2008 - April 30, 2014
  • Total Award Amount

  • 322370.00
  • Direct Costs

  • 275544.00
  • Sponsor Award Id

  • ITN10195
  • Contributor

  • W. Winn Chatham MD   Principal Investigator